Analide derivatives as monocyte chemoattractant protein-1 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 711-715

Informa Healthcare

Access to resources Recommend Favorite

Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease

By Fernández-Cruz A.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Tranilast inhibits interleukin-1 -induced monocyte chemoattractant protein-1 expression in rat mesangial cells

By Chikaraishi A.   Hirahashi J.   Takase O.   Marumo T.   Hishikawa K.   Hayashi M.   Saruta T.  

European Journal of Pharmacology, Vol. 427, Iss. 2, 2001-09 ,pp. : 151-158

Elsevier

Access to resources Recommend Favorite

Homocysteine stimulates monocyte chemoattractant protein-1 expression in mesangial cells via NF-κB activation

By Cheung Giselle T.Y.   Siow Yaw L.   O Karmin  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 3, 2008-03 ,pp. : 88-96

NRC Research Press

Access to resources Recommend Favorite

Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium

By Lee Yong   Lee Won   Kim Paul  

Inflammation Research, Vol. 59, Iss. 9, 2010-09 ,pp. : 755-765

Springer Publishing Company

Access to resources Recommend Favorite